Transcription factor, SP1, in epiretinal membranes of patients with proliferative diabetic retinopathy

Diabetes Research and Clinical Practice

Volumn 87, Issue 3, 2010, Pages

  Yoshida Hata, Natsuyo ^a   Mitamura, Yoshinori ^a   Oshitari, Toshiyuki ^a   Namekata, Kazuhiko ^b   Harada, Chikako ^b   Harada, Takayuki ^b   Yamamoto, Shuichi ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Angiogenesis; Diabetic retinopathy; SP1; Transcription factor; Vascular endothelial growth factor

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR SP1; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; EPIRETINAL MEMBRANE; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

DIABETIC RETINOPATHY; EPIRETINAL MEMBRANE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; RETINA; RETINAL VESSELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SP1 TRANSCRIPTION FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77649184347     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.12.008     Document Type: Article

References (8)

1. Mitamura Y., Harada C., and Harada T. Role of cytokines and trophic factors in the pathogenesis of diabetic retinopathy. Curr. Diabetes Rev. 1 (2005) 73-81
2. Abu El-Asrar A.M., Missotten L., and Geboes K. Expression of hypoxia-inducible factor-1alpha and the protein products of its target genes in diabetic fibrovascular epiretinal membranes. Br. J. Ophthalmol. 91 (2007) 822-826
3. Shi Q., Le X., Abbruzzese J.L., Peng Z., Qian C.N., Tang H., et al. Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res. 61 (2001) 4143-4154
4. Jośko J., and Mazurek M. Transcription factors having impact on vascular endothelial growth factor (VEGF) gene expression in angiogenesis. Med. Sci. Monit. 10 (2004) RA89-98
5. Mitamura Y., Okumura A., Harada C., Namekata K., Nakamura K., Tashimo A., et al. Activator protein-1 in epiretinal membranes of patients with proliferative diabetic retinopathy. Diabetologia 49 (2006) 209-211
6. Harada T., Harada C., Mitamura Y., Akazawa C., Ohtsuka K., Ohno S., et al. Neurotrophic factor receptors in epiretinal membranes after human diabetic retinopathy. Diabetes Care 25 (2002) 1060-1065
7. Hata Y., Duh E., Zhang K., Robinson G.S., and Aiello L.P. Transcription factors Sp1 and Sp3 alter vascular endothelial growth factor receptor expression through a novel recognition sequence. J. Biol. Chem. 273 (1998) 19294-19303
8. Arevalo J.F., and Garcia-Amaris R.A. Intravitreal bevacizumab for diabetic retinopathy. Curr. Diabetes Rev. 5 (2009) 39-46